Skip to content

Warenkorb

Der Warenkorb ist leer.

Gesamt (exkl. MwSt.) £0,00
Warenkorb überprüfen & bezahlen

WERI-Rb-1 Cells - Head-Neck cancer cell lines

Produktgrößen
1 each
£607,00
300632-1EACH
Über dieses Produkt
SKU:
300632
Zusätzliche Namen:
WERI-RB-1, WERI-Rb 1, WERI-Rb1, WERI-RB1, WERI Rb-1, WERIRb1, WERI, Wills Eye Research Institute-Retinoblastoma-1
Anwendung:
Tissue Culture
CE/IVD:
Our cells are provided for in vitro laboratory research purposes exclusively and are not intended fo
Weitere Details:
The WERI-Rb-1 cell line is derived from a retinoblastoma, a rare malignant tumor of the retina that typically manifests in early childhood. This cell line was established to provide a consistent and replicable model for the study of retinoblastoma biology, offering insights into the genetic, molecular, and cellular mechanisms underlying this form of cancer. WERI-Rb-1 cells are particularly valued in oncological research for their utility in investigating the pathophysiological processes and potential therapeutic targets for retinoblastoma. WERI-Rb-1 cells exhibit characteristics typical of retinoblastoma, including the expression of neuronal markers and the capability to form cell aggregates resembling Flexner-Wintersteiner rosettes, a hallmark of retinoblastoma histology. These cells have been used extensively to study the role of oncogenes and tumor suppressor genes in cancer development, with a focus on the RB1 gene, mutations of which are pivotal in the etiology of retinoblastoma. Furthermore, WERI-Rb-1 serves as an important tool in the evaluation of chemotherapeutic agents and novel drug delivery systems aimed at improving treatment outcomes for retinoblastoma patients.
Versandbedingungen:
Dry Ice
Lagerbedingungen:
Liquid N2, -70[o]C Avoid freeze/thaw cycles.
Hersteller:
Cytion
Typ:
Cells: Cell Lines